410 related articles for article (PubMed ID: 9013763)
1. Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription.
Yen PM; Liu Y; Palvimo JJ; Trifiro M; Whang J; Pinsky L; Jänne OA; Chin WW
Mol Endocrinol; 1997 Feb; 11(2):162-71. PubMed ID: 9013763
[TBL] [Abstract][Full Text] [Related]
2. Transfection with steroid-responsive reporter constructs shows glucocorticoid rather than androgen responsiveness in cultured Sertoli cells.
Denolet E; Gendt KD; Swinnen JV; Verrijdt G; Deboel L; Roskams T; Verhoeven G
J Steroid Biochem Mol Biol; 2006 Feb; 98(2-3):164-73. PubMed ID: 16388947
[TBL] [Abstract][Full Text] [Related]
3. Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene.
Rennie PS; Bruchovsky N; Leco KJ; Sheppard PC; McQueen SA; Cheng H; Snoek R; Hamel A; Bock ME; MacDonald BS
Mol Endocrinol; 1993 Jan; 7(1):23-36. PubMed ID: 8446105
[TBL] [Abstract][Full Text] [Related]
4. Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants.
de Lange P; Koper JW; Huizenga NA; Brinkmann AO; de Jong FH; Karl M; Chrousos GP; Lamberts SW
Mol Endocrinol; 1997 Jul; 11(8):1156-64. PubMed ID: 9212062
[TBL] [Abstract][Full Text] [Related]
5. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome.
Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT
Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864
[TBL] [Abstract][Full Text] [Related]
6. Ephemerally expressed wild-type and mutant steroid hormone receptors are equally able to influence expression of transient or resident templates.
Schneider S; Brenz Verca S; Rusconi S
C R Acad Sci III; 1995 Nov; 318(11):1095-100. PubMed ID: 8574786
[TBL] [Abstract][Full Text] [Related]
7. Quantitative differences in androgen and glucocorticoid receptor DNA binding properties contribute to receptor-selective transcriptional regulation.
Rundlett SE; Miesfeld RL
Mol Cell Endocrinol; 1995 Mar; 109(1):1-10. PubMed ID: 7789609
[TBL] [Abstract][Full Text] [Related]
8. Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumor virus promoter.
Lee KI; Reddy EP; Reddy CD
J Biol Chem; 1995 Oct; 270(41):24502-8. PubMed ID: 7592667
[TBL] [Abstract][Full Text] [Related]
9. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
Culig Z; Stober J; Gast A; Peterziel H; Hobisch A; Radmayr C; Hittmair A; Bartsch G; Cato AC; Klocker H
Cancer Detect Prev; 1996; 20(1):68-75. PubMed ID: 8907206
[TBL] [Abstract][Full Text] [Related]
10. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
[TBL] [Abstract][Full Text] [Related]
11. Analysis of glucocorticoid and androgen receptor gene fusions delineates domains required for transcriptional specificity.
Whitacre DC; Karnas KJ; Miesfeld RL
Endocrine; 2001 Jun; 15(1):111-8. PubMed ID: 11572317
[TBL] [Abstract][Full Text] [Related]
12. Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation.
Rundlett SE; Wu XP; Miesfeld RL
Mol Endocrinol; 1990 May; 4(5):708-14. PubMed ID: 2274054
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid and progestin receptors are differently involved in the cooperation with a structural element of the mouse mammary tumor virus promoter.
Le Ricousse S; Gouilleux F; Fortin D; Joulin V; Richard-Foy H
Proc Natl Acad Sci U S A; 1996 May; 93(10):5072-7. PubMed ID: 8643531
[TBL] [Abstract][Full Text] [Related]
14. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor.
Govindan MV
Mol Endocrinol; 1990 Mar; 4(3):417-27. PubMed ID: 2342476
[TBL] [Abstract][Full Text] [Related]
15. Comparison of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter by the androgen and glucocorticoid receptor.
List HJ; Lozano C; Lu J; Danielsen M; Wellstein A; Riegel AT
Exp Cell Res; 1999 Aug; 250(2):414-22. PubMed ID: 10413595
[TBL] [Abstract][Full Text] [Related]
16. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
[TBL] [Abstract][Full Text] [Related]
17. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
[TBL] [Abstract][Full Text] [Related]
18. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE
Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
20. Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination.
Zhang S; Liang X; Danielsen M
Mol Endocrinol; 1996 Jan; 10(1):24-34. PubMed ID: 8838142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
